$184 Million is the total value of Northpond Ventures, LLC's 5 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DICE THERAPEUTICS INC | $102,737,575 | +53.8% | 3,292,871 | 0.0% | 55.73% | +19.1% | ||
VIGIL NEUROSCIENCE INC | $52,681,225 | +37.4% | 4,214,498 | 0.0% | 28.58% | +6.3% | ||
ISOPLEXIS CORP | $13,653,223 | -9.9% | 8,808,531 | 0.0% | 7.41% | -30.2% | ||
DNAY | TELESIS BIO INC | $11,812,956 | -27.7% | 9,844,130 | 0.0% | 6.41% | -44.0% | |
CANDEL THERAPEUTICS INC | $3,464,035 | -43.0% | 1,935,215 | 0.0% | 1.88% | -55.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-01
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TELESIS BIO INC | 8 | Q3 2023 | 37.2% |
CANDEL THERAPEUTICS INC | 8 | Q3 2023 | 6.0% |
VIGIL NEUROSCIENCE INC | 7 | Q3 2023 | 65.8% |
DICE THERAPEUTICS INC | 6 | Q1 2023 | 55.7% |
ISOPLEXIS CORP | 5 | Q4 2022 | 28.3% |
PHENOMEX INC | 2 | Q2 2023 | 4.4% |
View Northpond Ventures, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
SC 13D/A | 2023-06-02 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-01 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-01 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-15 |
View Northpond Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.